We offer dedicated reagent kits designed for use with our fully automated ELISA platform “KI‑ZA‑SHI”, as well as ELISA kits intended for research applications.
These reagents are engineered to enable stable and reliable measurement of ultra‑trace biomarkers in blood.
As integral components of the platform, the reagents play a critical role in ensuring measurement reproducibility and quantitative performance.
 

pTau217 (phosphorylated tau 217) is a biomarker attracting significant attention in Alzheimer’s disease research.
Recent studies have increasingly reported that fluctuations in blood pTau217 levels may be associated with neurodegenerative processes.
This kit is designed for the quantitative evaluation of pTau217 in research settings.

mid‑pTau181 targets phosphorylation at a specific region of the tau protein.
It is widely used as an indicator in neurodegenerative disease research, contributing to disease‑mechanism studies and drug‑discovery efforts.
This kit is engineered to deliver stable and consistent measurements for research use.
 

Our current focus includes the following research domains:

• Alzheimer’s disease
• Other neurodegenerative disorders
• Mild cognitive impairment (MCI) research
• Neuroinflammation‑related studies

Blood‑based biomarkers are gaining importance in research aimed at early disease detection and understanding disease progression.

Our reagents support stable operation and long‑term use of the system after installation.
Key characteristics include:

• Integrated design optimized for the instrument
• Configuration emphasizing reproducibility
• Compatibility with future expansion of target biomarkers

This approach enables the establishment of a sustainable research infrastructure centered around the KI‑ZA‑SHI platform.

All reagents described on this page are provided for Research Use Only (RUO).
They are not intended for clinical diagnostic purposes.